indazoles has been researched along with Lupus Erythematosus, Cutaneous, Subacute in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beato-Merino, M; Casado-Verrier, B; Delgado-Mucientes, C; Pérez-Santos, S | 1 |
1 other study(ies) available for indazoles and Lupus Erythematosus, Cutaneous, Subacute
| Article | Year |
|---|---|
Subacute cutaneous lupus erythematosus induced by the new multikinase inhibitor pazopanib.
Topics: Aged; Antineoplastic Agents; Carcinoma, Renal Cell; Drug Eruptions; Humans; Indazoles; Kidney Neoplasms; Lupus Erythematosus, Cutaneous; Male; Pyrimidines; Sulfonamides | 2014 |